AYTU BIOPHARMA, INC Related Party Transaction, Expenses from Transactions with Related Party
AYTU BIOPHARMA, INC (AYTU) reported Related Party Transaction, Expenses from Transactions with Related Party of $1.05 thousand for the 3-month period ending 2015-02-28, per its 10-Q filed 2015-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2015-04-15
- AYTU BIOPHARMA, INC related party transaction, expenses from transactions with related party for the quarter ending 2015-02-28 was $1.05K, a 75.00% increase year-over-year.
- AYTU BIOPHARMA, INC related party transaction, expenses from transactions with related party for the quarter ending 2014-11-30 was $1.65K, a 44.74% increase year-over-year.
- AYTU BIOPHARMA, INC related party transaction, expenses from transactions with related party for the quarter ending 2014-05-31 was $900.00, a 56.94% decline year-over-year.
- AYTU BIOPHARMA, INC related party transaction, expenses from transactions with related party for the quarter ending 2014-02-28 was $600.00, a 42.86% decline year-over-year.
- AYTU BIOPHARMA, INC related party transaction, expenses from transactions with related party for fiscal 2013 was $6.18K, a 15.80% decline from fiscal 2012.
- AYTU BIOPHARMA, INC related party transaction, expenses from transactions with related party for fiscal 2012 was $7.34K, a 72.71% increase from fiscal 2011.
- AYTU BIOPHARMA, INC related party transaction, expenses from transactions with related party for fiscal 2011 was $4.25K.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month | Related Party Transaction, Expenses from Transactions with Related Party 12 month | Related Party Transaction, Expenses from Transactions with Related Party 81 month | Related Party Transaction, Expenses from Transactions with Related Party 84 month | Related Party Transaction, Expenses from Transactions with Related Party 87 month | Related Party Transaction, Expenses from Transactions with Related Party 90 month | Related Party Transaction, Expenses from Transactions with Related Party 93 month | Related Party Transaction, Expenses from Transactions with Related Party 96 month | Related Party Transaction, Expenses from Transactions with Related Party 99 month | Related Party Transaction, Expenses from Transactions with Related Party 102 month | Related Party Transaction, Expenses from Transactions with Related Party 105 month | Related Party Transaction, Expenses from Transactions with Related Party 108 month | Related Party Transaction, Expenses from Transactions with Related Party 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-02-28 | $1.05K 10-Q · filed 2015-04-15 | $2.70K 10-Q · filed 2015-04-15 | |||||||||||||
| 2014-11-30 | $1.65K 10-Q · filed 2015-01-12 | ||||||||||||||
| 2014-05-31 | $900.00 10-Q · filed 2014-07-10 | $1.50K derived: sum of 2 quarters · filed 2015-04-15 | $2.64K 10-Q · filed 2014-07-10 | $3.33K derived: sum of 4 quarters · filed 2015-04-15 | $38.97K 10-Q · filed 2014-07-10 | ||||||||||
| 2014-02-28 | $600.00 10-Q · filed 2015-04-15 | $1.74K 10-Q · filed 2015-04-15 | $2.43K derived: sum of 3 quarters · filed 2015-04-15 | $4.52K derived: sum of 4 quarters · filed 2015-04-15 | $38.07K 10-Q · filed 2014-04-11 | ||||||||||
| 2013-11-30 | $1.14K 10-Q · filed 2015-01-12 | $1.83K derived: sum of 2 quarters · filed 2015-01-12 | $3.92K derived: sum of 3 quarters · filed 2015-01-12 | $4.97K derived: sum of 4 quarters · filed 2015-01-12 | $37.47K 10-Q · filed 2014-01-10 | ||||||||||
| 2013-08-31 | $690.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $2.78K derived: sum of 2 quarters · filed 2014-11-26 | $3.83K derived: sum of 3 quarters · filed 2014-11-26 | $6.18K 10-K · filed 2014-11-26 | $36.33K 10-K · filed 2014-11-26 | ||||||||||
| 2013-05-31 | $2.09K 10-Q · filed 2014-07-10 | $3.14K derived: sum of 2 quarters · filed 2014-04-11 | $5.49K 10-Q · filed 2014-07-10 | $8.69K derived: sum of 4 quarters · filed 2014-11-26 | $35.64K 10-Q · filed 2013-06-28 | ||||||||||
| 2013-02-28 | $1.05K 10-Q · filed 2014-04-11 | $3.40K 10-Q · filed 2014-04-11 | $6.60K derived: sum of 3 quarters · filed 2014-11-26 | $8.34K derived: sum of 4 quarters · filed 2014-11-26 | $33.55K 10-Q · filed 2013-04-15 | ||||||||||
| 2012-11-30 | $2.35K 10-Q · filed 2014-01-10 | $5.55K derived: sum of 2 quarters · filed 2014-11-26 | $7.29K derived: sum of 3 quarters · filed 2014-11-26 | $8.04K derived: sum of 4 quarters · filed 2014-11-26 | $32.50K 10-Q · filed 2013-01-14 | ||||||||||
| 2012-08-31 | $3.20K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $4.94K derived: sum of 2 quarters · filed 2014-11-26 | $5.69K derived: sum of 3 quarters · filed 2014-11-26 | $7.34K 10-K · filed 2014-11-26 | $30.15K 10-K · filed 2012-11-29 | ||||||||||
| 2012-05-31 | $1.74K 10-Q · filed 2012-06-26 | $2.49K derived: sum of 2 quarters · filed 2013-06-28 | $4.14K 10-Q · filed 2013-06-28 | $26.95K 10-Q · filed 2012-06-26 | |||||||||||
| 2012-02-29 | $750.00 10-Q · filed 2012-04-12 | $2.40K 10-Q · filed 2013-04-15 | $25.21K 10-Q · filed 2012-04-12 | ||||||||||||
| 2012-02-28 | $750.00 10-Q · filed 2013-04-15 | $2.40K derived: sum of 2 quarters · filed 2013-04-15 | $3.80K derived: sum of 3 quarters · filed 2013-04-15 | $4.70K derived: sum of 4 quarters · filed 2013-04-15 | |||||||||||
| 2011-11-30 | $1.65K 10-Q · filed 2013-01-14 | $3.05K derived: sum of 2 quarters · filed 2013-01-14 | $3.95K derived: sum of 3 quarters · filed 2013-01-14 | $5.00K derived: sum of 4 quarters · filed 2013-01-14 | $24.46K 10-Q · filed 2011-12-23 | ||||||||||
| 2011-08-31 | $1.40K derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29 | $2.30K derived: sum of 2 quarters · filed 2012-11-29 | $3.35K derived: sum of 3 quarters · filed 2012-11-29 | $4.25K 10-K · filed 2012-11-29 | |||||||||||
| 2011-05-31 | $900.00 10-Q · filed 2012-06-26 | $1.95K derived: sum of 2 quarters · filed 2012-06-26 | $2.85K 10-Q · filed 2012-06-26 | ||||||||||||
| 2011-02-28 | $1.05K 10-Q · filed 2012-04-12 | $1.95K 10-Q · filed 2012-04-12 | |||||||||||||
| 2010-11-30 | $900.00 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |